Multiplex cytokine detection: key points for method selection and quality control

Characteristics of common multiplex assay platforms

Cytokines are a class of small-molecule soluble proteins secreted by immune cells and some non-immune cells, involved in cell communication, immune regulation, and inflammatory responses. In research and clinical testing, accurate quantification of cytokines often requires selecting an appropriate platform based on sample type, throughput requirements, and sensitivity. Common methods include enzyme-linked immunosorbent assay (ELISA), cytometric bead array (CBA), chemiluminescence immunoassay, and fluorescence-labeled bead-based multiplex detection systems.

As a classic method, ELISA generally offers high sensitivity and a low equipment threshold, making it suitable for single or few-analyte detection; its limitations are that only one analyte can be measured at a time and sample consumption is relatively high. CBA and multiplex bead-based methods coat capture antibodies onto microspheres with different fluorescence intensities, enabling simultaneous detection of dozens of cytokines in the same sample, which helps analyze the overall profile of immune responses, but the workflow is relatively complex and places higher demands on standard curve fitting and lot-to-lot consistency.

Common issues in sample processing and validation

Serum, plasma, cell culture supernatant, and tissue homogenate are the most common sample types in cytokine detection. Different anticoagulants may interfere with results, and it is generally recommended to fix the sample type and pre-processing conditions during the protocol design stage. For example, heparin-anticoagulated plasma and serum may show different baseline levels in some cytokine assays, so mixing them within the same experiment is not recommended.

Laboratories typically need to complete performance validation before formal testing, including precision, recovery, linear dilution, and lower limit of quantification. The stability of cytokines in samples is greatly affected by temperature, the number of freeze-thaw cycles, and storage time. It is generally recommended to aliquot samples and store them at -80°C or below, avoiding repeated freeze-thaw cycles. For low-abundance cytokines, concentration or high-sensitivity reagent systems may be used, but matrix effects must be carefully evaluated.

Quality control and data interpretation

Quality control for cytokine detection runs through pre-analytical, analytical, and post-analytical stages. It is recommended to include a standard curve, quality control samples, and a blank control in each batch, and the measured values of quality control samples should fall within the acceptable range. In multiplex assays, cross-reactivity between different analytes and microsphere aggregation should also be monitored. Data interpretation should be combined with biological context, avoiding conclusions drawn from a single result alone.

In in vitro diagnostic settings, relevant reagents must comply with medical device quality management system requirements, and manufacturers generally provide analytical performance specifications and intended use statements. Users should conduct methodological comparisons and confirm clinical intended use based on their own testing purposes. Overall, rational platform selection, standardized sample processing, and establishment of a stable quality control workflow are the foundation for obtaining reliable cytokine data.